MediXall Group Statistics
MediXall Group (MDXL) Stock Statistics & Valuation Metrics
Total Valuation
MediXall Group has a market cap or net worth of $753.71K. The enterprise value is $4.97T.
- Market Cap
- $753.71K
- Enterprise Value
- $4.97T
Share Statistics
MediXall Group has 228,396,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 228,396,800
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
MediXall Group’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 145.40%.
- Return on Equity (ROE)
- 0.70
- Return on Assets (ROA)
- -22.69
- Return on Invested Capital (ROIC)
- 145.40%
- Return on Capital Employed (ROCE)
- 0.60
- Revenue Per Employee
- 44.20K
- Profits Per Employee
- -651.92K
- Employee Count
- 7
- Asset Turnover
- 1.54
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of MediXall Group is -0.09. MediXall Group’s PEG ratio is 0.00.
- PE Ratio
- -0.09
- PS Ratio
- 2.19
- PB Ratio
- -0.06
- Price to FCF
- -0.55
- Price to Operating Cash Flow
- -0.34
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, MediXall Group had revenue of 309.42K and earned -4.56M in profits. Earnings per share was -0.04.
- Revenue
- 309.42K
- Gross Profit
- 72.91K
- Operating Income
- -3.92M
- Pretax Income
- -4.56M
- Net Income
- -4.56M
- EBITDA
- -3.88M
- Earnings Per Share (EPS)
- -0.04
Cash Flow
In the last 12 months, operating cash flow was -1.20M and capital expenditures 0, giving a free cash flow of -1.20M billion.
- Operating Cash Flow
- -1.20M
- Free Cash Flow
- -1.20M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
MediXall Group pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -181.30%
- Earnings Yield
- -1087.43%
Stock Price Statistics
- Beta
- 19.07
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.38
- 200-Day Moving Average
- 0.38
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
MediXall Group as a current ratio of 0.00, with Debt / Equity ratio of -58.71%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 75.30
- Net Debt to EBITDA
- -0.98
- Interest Coverage Ratio
- -6.05
Taxes
In the past 12 months, MediXall Group has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
MediXall Group EV to EBITDA ratio is -1.16, with an EV/FCF ratio of -3.66.
- EV to Sales
- 14.54
- EV to EBITDA
- -1.16
- EV to Free Cash Flow
- -3.66
- EV to Operating Cash Flow
- -3.66
Balance Sheet
MediXall Group has $31.92K in cash and marketable securities with $430.43K in debt, giving a net cash position of -$398.51K billion.
- Cash & Marketable Securities
- $31.92K
- Total Debt
- $430.43K
- Net Cash
- -$398.51K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.02
Margins
Gross margin is 23.56%, with operating margin of -1265.64%, and net profit margin of -1474.82%.
- Gross Margin
- 23.56%
- Operating Margin
- -1265.64%
- Pretax Margin
- -1474.82%
- Net Profit Margin
- -1474.82%
- EBITDA Margin
- -1254.56%
- EBIT Margin
- -1265.64%
Analyst Forecast
The average price target for MediXall Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―

